Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Prostate. 2010 Sep 21;71(4):394–402. doi: 10.1002/pros.21253

Table 3d.

Cumulative risk model limited to the risk alleles that were significantly over-represented in CaP patients with a “normal” PSA and DRE and a positive family*

Carrier of Variants
#
Case N=195
N= (%)
Control N=348 N= (%) OR
(95%C.I.)
p-value
0 3 (1.5) 18 (5.2) --
1 13 (6.7) 65 (18.7) 1.2 (0.3-4.6) 0.79
2 44 (22.6) 118 (33.9) 2.2 (0.6-8.0) 0.21
3 64 (32.8) 101 (29.0) 3.8 (1.1-13.4) 0.038
4-7 71 (36.4) 46 (13.2) 9.3 (2.6-33.2) <0.0001
*

P-trend <0.001

*

Analyses were limited to cases (n=195) and controls (n=338) with available family history information